Skip to main content

Market Overview

Stifel Nicolaus Downgrades Auxilium Pharmaceuticals To Hold, Shares Drop


Analysts at Stifel Nicolaus downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Hold and removed the price target of $30.00.

Auxilium Pharmaceuticals shares have surged 65.64% over the past 52 weeks, while the S&P 500 index has gained 18.13% in the same period.

Auxilium Pharmaceuticals' shares dropped 1.41% to $30.70 in pre-market trading.

Latest Ratings for AUXL

Oct 2014MizuhoDowngradesBuyNeutral
Oct 2014MKM PartnersDowngradesBuyNeutral
Sep 2014RBC CapitalDowngradesOutperformSector Perform

View More Analyst Ratings for AUXL
View the Latest Analyst Ratings


Related Articles (AUXL)

View Comments and Join the Discussion!

Posted-In: Stifel NicolausDowngrades Analyst Ratings

Latest Ratings

ESMorgan StanleyMaintains87.0
EIXMorgan StanleyMaintains73.0
EDMorgan StanleyMaintains73.0
LYFTNomuraInitiates Coverage On
DUKMorgan StanleyMaintains108.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at